Does MEGLUMINE Cause Gait inability? 163 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 163 reports of Gait inability have been filed in association with MEGLUMINE. This represents 27.9% of all adverse event reports for MEGLUMINE.
163
Reports of Gait inability with MEGLUMINE
27.9%
of all MEGLUMINE reports
162
Deaths
160
Hospitalizations
How Dangerous Is Gait inability From MEGLUMINE?
Of the 163 reports, 162 (99.4%) resulted in death, 160 (98.2%) required hospitalization, and 160 (98.2%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEGLUMINE. However, 163 reports have been filed with the FAERS database.
What Other Side Effects Does MEGLUMINE Cause?
Off label use (389)
Maternal exposure during pregnancy (300)
Joint swelling (294)
Pemphigus (289)
Glossodynia (288)
Inflammation (285)
Pain (284)
General physical health deterioration (283)
Folliculitis (282)
Hypertension (282)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which MEGLUMINE Alternatives Have Lower Gait inability Risk?
MEGLUMINE vs MELATONIN
MEGLUMINE vs MELOXICAM
MEGLUMINE vs MELPERONE
MEGLUMINE vs MELPHALAN
MEGLUMINE vs MEMANTINE